E
Sernova Biotherapeutics Inc SVA.TO
TSX
Recommendation
Prev Close
$0.19
Volume
--
Avg Vol (90D)
142,770
Market Cap
$44.94M
Dividend & Yield
--
52-Week Range
$0.15 - $0.465
P/E (TTM)
--
EPS (TTM)
-$0.066
My Lists My Alerts
Access our Premium Ratings
Get Access
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
Vivo Capital Launches Legal Action Against Sinovac Biotech's Board Over Governance Issues (SVA) ...
4/24/2025 - GuruFocus
Sinovac Biotech shareholder announces legal proceedings regarding board
4/24/2025 - The Fly
Vivo Capital Files Lawsuits to Protect Sinovac Shareholders from the New Boards Value Destructive Actions
4/24/2025 - Business Wire
Sinovac Biotech (SVA) Faces Auditor Exit, Delays SEC Filing Amid Board Uncertainty SVA Stock News
4/22/2025 - GuruFocus
Sinovac Biotech issues statement regarding resignation of auditor
4/22/2025 - The Fly
SINOVAC Management Statement Regarding Auditor Resignation
4/22/2025 - Globe Newswire
Sinovac Biotech Faces Audit Challenges Amid Board Legitimacy Issues
4/21/2025 - TipRanks Financial Blog
Heng Ren Partners Calls on Sinovac to Disclose the Record and Payment Dates of the Special Dividend and Distribute an Additional Dividend of $41 per Share
4/10/2025 - PR Newswire
Heng Ren Partners Calls on Sinovac to Disclose the Record and Payment Dates of the Special Dividend and Distribute an Additional Dividend of $41 per Share
4/10/2025 - CNW Group - News Releases
Sinovac Biotech to declare $55.00 per share special cash dividend
4/1/2025 - The Fly
SINOVAC Announces Decision to Declare Cash Dividend
4/1/2025 - Business Wire
SINOVAC Announces New Board Member and Chairman of the Audit Committee
3/28/2025 - Business Wire
Heng Ren 'demands' Sinovac Biotech distribute $8.9B in cash to shareholders
3/21/2025 - Yahoo! Finance: News
Heng Ren 'demands' Sinovac Biotech distribute $8.9B in cash to shareholders
3/20/2025 - TipRanks Financial Blog
Heng Ren 'demands' Sinovac Biotech distribute $8.9B in cash to shareholders
3/20/2025 - The Fly
Heng Ren Partners Demands Sinovac Distribute $8.9 Billion in Cash to its Shareholders and Cause Reinstatement of Trading
3/20/2025 - CNW Group - News Releases
Heng Ren Partners Demands Sinovac Distribute $8.9 Billion in Cash to its Shareholders and Cause Reinstatement of Trading
3/20/2025 - PR Newswire
Sinovac Biotech announces new board pursuant to privy council judgement
2/28/2025 - TipRanks Financial Blog
Sinovac Biotech announces new board pursuant to privy council judgement
2/28/2025 - The Fly
SINOVAC Announces New Board Pursuant to Privy Council Judgment and Order
2/28/2025 - Business Wire
SINOVAC Issues Statement Regarding Privy Council Judgment
1/16/2025 - Business Wire
Sinovac Biotech initiates clinical trial on a HFMD vaccine candidate
12/16/2024 - TipRanks Financial Blog
Sinovac Biotech initiates clinical trial on a HFMD vaccine candidate
12/16/2024 - The Fly
SINOVAC Initiated a Phase III Clinical Trial on Bivalent Vaccine Against Hand Foot and Mouth Disease (HFMD)
12/16/2024 - Business Wire
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
-$19.00M
EBIT (TTM)
-$19.25M
Net Income (TTM)
-$20.48M
Balance Sheet
Total Assets (Q)
$2.13M
Total Debt (Q)
$377.60K
Total Liabilities (Q)
$14.51M
Book Value Per Share (Q)
-$0.0377
Cash Flow
Cash from Operations (TTM)
-$14.15M
Cash from Investing (TTM)
$6.63M
Cash from Financing (TTM)
$3.76M
Net Change in Cash (TTM)
-$3.76M
Filings
Filing Date
Friday, March 14, 2025
Period Date
Tuesday, December 31, 2024
Next Filing
Week of May 5 and 9 (est)
Price History
Loading...
Beta
-1.05
7-Day Total Return
10.81%
30-Day Total Return
17.14%
60-Day Total Return
-2.38%
90-Day Total Return
-10.87%
Year to Date Total Return
-10.87%
1-Year Total Return
-53.41%
2-Year Total Return
-74.38%
3-Year Total Return
-85.14%
5-Year Total Return
32.26%
52-week Low
Mar 27, 2025 - $0.15
52-week High
Apr 29, 2024 - $0.465
Valuation
Market Cap
$44.94M - Nano Cap
Enterprise Value
$44.46M
Price/Sales (TTM)
--
Price/Book (Q)
-5.04
Dividends and Shares
Shares Outstanding
327.47M
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
www.sernova.com
Phone Number
519 858 5184
Address
700 Collip Circle
London, ON N6G 4X8
Country
Canada
Year Founded
--
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
Sernova Biotherapeutics Inc operates as a clinical-stage biotechnology company in Canada. The company develops regenerative medicine therapeutics comprising proprietary Cell Pouch, a bio-hybrid... more